NICHOLAS MAGGIO: Open Payments
NPI 1295398808 · CLINTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 42 payments from 13 companies in 2025. Trend: 2023 $1,556 · 2024 $879 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $190 |
| Dexcom, Inc. | 4 | $89 |
| Abbott Laboratories | 4 | $82 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Lilly USA, LLC | 4 | $69 |
| Edwards Lifesciences Corporation | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| PFIZER INC. | 1 | $22 |
| ABBVIE INC. | 1 | $21 |
Products named: Dexcom G6 Transmitter, Ozempic, FREESTYLE LIBRE 3, Rybelsus, MOUNJARO, TRELEGY ELLIPTA, Kerendia, VOQUEZNA.
Industry payments across LA — which companies pay providers there.
